Country: United States
Language: English
Source: NLM (National Library of Medicine)
AZELAIC ACID (UNII: F2VW3D43YT) (AZELAIC ACID - UNII:F2VW3D43YT)
Intendis Inc.
AZELAIC ACID
AZELAIC ACID 0.15 g in 1 g
TOPICAL
PRESCRIPTION DRUG
FINACEA Gel, 15%, is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. Although some reduction of erythema which was present in patients with papules and pustules of rosacea occurred in clinical studies, efficacy for treatment of erythema in rosacea in the absence of papules and pustules has not been evaluated. Patients should be instructed to avoid spicy foods, thermally hot foods and drinks, alcoholic beverages and to use only very mild soaps or soapless cleansing lotion for facial cleansing. FINACEA Gel, 15%, is contraindicated in individuals with a history of hypersensitivity to propylene glycol or any other component of the formulation.
FINACEA Gel, 15%, is supplied in tubes in the following size: FINACEA Gel, 15% – 50 g tube – NDC 10922-825-02 Storage Store at 25°C (77°F); excursions permitted between 15–30°C (59–86°F) [see USP Controlled Room Temperature]. Distributed under license; U.S. Patent No 6,534,070 www.myfinacea.com © 2010, Intendis, Inc. All rights reserved. July 2010 Manufactured by Intendis Manufacturing S.p.A., Segrate, Milan, Italy Distributed by: Intendis Morristown, NJ 07962 Intendis is part of the Bayer Group 6706803
New Drug Application
FINACEA- AZELAIC ACID GEL FINACEA- AZELAIC ACID INTENDIS INC. ---------- FINACEA (AZELAIC ACID) GEL, 15% FOR DERMATOLOGIC USE ONLY-NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE RX ONLY DESCRIPTION FINACEA (azelaic acid) Gel, 15%, contains azelaic acid, a naturally occurring saturated dicarboxylic acid. Chemically, azelaic acid is 1,7-heptanedicarboxylic acid, with the molecular formula C H O , a molecular weight of 188.22, and the structural formula: Azelaic acid is a white, odorless crystalline solid that is poorly soluble in water at 20°C (0.24%), but freely soluble in boiling water and in ethanol. Each gram of FINACEA Gel, 15%, contains 0.15 gm azelaic acid (15% w/w) as the active ingredient in an aqueous gel base containing benzoic acid (as a preservative), disodium EDTA, lecithin, medium- chain triglycerides, polyacrylic acid, polysorbate 80, propylene glycol, purified water, and sodium hydroxide to adjust pH. CLINICAL PHARMACOLOGY The mechanism(s) by which azelaic acid interferes with the pathogenic events in rosacea are unknown. PHARMACOKINETICS : The percutaneous absorption of azelaic acid after topical application of FINACEA Gel, 15%, could not be reliably determined. Mean plasma azelaic acid concentrations in rosacea patients treated with FINACEA Gel, 15%, twice daily for at least 8 weeks are in the range of 42 to 63.1 ng/mL. These values are within the maximum concentration range of 24.0 to 90.5 ng/mL observed in rosacea patients treated with vehicle only. This indicates that FINACEA Gel, 15%, does not increase plasma azelaic acid concentration beyond the range derived from nutrition and endogenous metabolism. _In vitro_ and human data suggest negligible cutaneous metabolism of H-azelaic acid 20% cream after topical application. Azelaic acid is mainly excreted unchanged in the urine, but undergoes some ß- oxidation to shorter chain dicarboxylic acids. CLINICAL STUDIES FINACEA Gel, 15%, was evaluated for the treatment of mild to moderate papulopustular rosacea in 2 clinical trials comprising a total o Read the complete document